Our Opinion

Akari Therapeutics Plc is on the Cruelty Free Investing use of animals list because they exploit animals for drug testing.

Additional resources:

Akari Therapeutics Announces Receipt of Orphan Drug Designation for Coversin from the U.S. FDA for Treatment of Guillain Barré Syndrome.

Company Description

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases.

Website: http://akaritx.com